BSE Live
Oct 10, 16:01Prev. Close
1763.10
Open Price
1702.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 10, 15:49Prev. Close
1760.20
Open Price
1740.10
Bid Price (Qty.)
1741.80 (3)
Offer Price (Qty.)
0.00 (0)
Key Financial Ratios of Hester Biosciences (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 36.70 | 51.55 | 35.92 | 29.32 | 22.60 | |
Diluted EPS (Rs.) | 36.70 | 51.55 | 35.92 | 29.32 | 22.60 | |
Cash EPS (Rs.) | 47.74 | 60.44 | 42.33 | 35.79 | 29.33 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 238.72 | 210.93 | 171.72 | 143.52 | 117.93 | |
Book Value [InclRevalReserve]/Share (Rs.) | 238.72 | 210.93 | 171.72 | 143.52 | 117.93 | |
Dividend / Share(Rs.) | 6.60 | 11.00 | 10.00 | 5.30 | 4.10 | |
Revenue from Operations/Share (Rs.) | 199.16 | 201.23 | 158.44 | 144.92 | 118.60 | |
PBDIT/Share (Rs.) | 65.41 | 83.30 | 60.51 | 49.14 | 40.28 | |
PBIT/Share (Rs.) | 54.38 | 74.40 | 54.10 | 42.67 | 33.54 | |
PBT/Share (Rs.) | 48.46 | 70.24 | 51.38 | 38.89 | 29.21 | |
Net Profit/Share (Rs.) | 36.70 | 51.55 | 35.92 | 29.32 | 22.60 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 32.84 | 41.39 | 38.18 | 33.90 | 33.96 | |
PBIT Margin (%) | 27.30 | 36.97 | 34.14 | 29.43 | 28.28 | |
PBT Margin (%) | 24.33 | 34.90 | 32.42 | 26.83 | 24.62 | |
Net Profit Margin (%) | 18.42 | 25.61 | 22.67 | 20.22 | 19.05 | |
Return on Networth / Equity (%) | 15.37 | 24.43 | 20.91 | 20.42 | 19.16 | |
Return on Capital Employed (%) | 21.12 | 31.49 | 27.38 | 17.26 | 15.83 | |
Return on Assets (%) | 11.26 | 18.25 | 14.51 | 13.97 | 12.10 | |
Total Debt/Equity (X) | 0.19 | 0.18 | 0.27 | 0.30 | 0.34 | |
Asset Turnover Ratio (%) | 61.12 | 71.25 | 64.03 | 69.09 | 63.52 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 2.12 | 2.53 | 2.10 | 2.20 | 1.79 | |
Quick Ratio (X) | 1.08 | 1.30 | 1.19 | 1.23 | 0.90 | |
Inventory Turnover Ratio (X) | 2.80 | 3.53 | 3.48 | 3.73 | 3.00 | |
Dividend Payout Ratio (NP) (%) | 19.07 | 23.38 | 16.70 | 8.98 | 18.14 | |
Dividend Payout Ratio (CP) (%) | 14.66 | 19.94 | 14.17 | 7.36 | 13.97 | |
Earnings Retention Ratio (%) | 80.93 | 76.62 | 83.30 | 91.02 | 81.86 | |
Cash Earnings Retention Ratio (%) | 85.34 | 80.06 | 85.83 | 92.64 | 86.03 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 821.00 | 1,344.37 | 1,391.26 | 673.82 | 453.63 | |
EV/Net Operating Revenue (X) | 4.85 | 7.85 | 10.32 | 5.47 | 4.50 | |
EV/EBITDA (X) | 14.75 | 18.97 | 27.03 | 16.12 | 13.24 | |
MarketCap/Net Operating Revenue (X) | 4.64 | 7.68 | 10.12 | 5.27 | 4.21 | |
Retention Ratios (%) | 80.92 | 76.61 | 83.29 | 91.01 | 81.85 | |
Price/BV (X) | 3.88 | 7.33 | 9.34 | 5.32 | 4.23 | |
Price/Net Operating Revenue | 4.64 | 7.68 | 10.12 | 5.27 | 4.21 | |
Earnings Yield | 0.04 | 0.03 | 0.02 | 0.04 | 0.05 |
01.08.2025
Hester Bio Standalone June 2025 Net Sales at Rs 63.49 crore, down 13.58% Y-o-Y
09.05.2025
Hester Bio Standalone March 2025 Net Sales at Rs 76.67 crore, up 5.21% Y-o-Y
09.05.2025
Hester Bio Consolidated March 2025 Net Sales at Rs 81.93 crore, up 3.37% Y-o-Y
31.01.2025
Hester Bio Consolidated December 2024 Net Sales at Rs 63.22 crore, down 5.62% Y-o-Y
01.08.2025
Hester Bio Standalone June 2025 Net Sales at Rs 63.49 crore, down 13.58% Y-o-Y
09.05.2025
Hester Bio Standalone March 2025 Net Sales at Rs 76.67 crore, up 5.21% Y-o-Y
09.05.2025
Hester Bio Consolidated March 2025 Net Sales at Rs 81.93 crore, up 3.37% Y-o-Y
31.01.2025
Hester Bio Consolidated December 2024 Net Sales at Rs 63.22 crore, down 5.62% Y-o-Y